Xiamen Jiashineng Electronic Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Xiamen Jiashineng Electronic Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include UGIFT. The owner is based in XIAMEN.

ROOM 301, #553, XINGLONG ROAD

XIAMEN 361000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

UGIFT
UGIFT
Registered 2020

Trademark Classifications

Xiamen Jiashineng Electronic Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Xiamen Jiashineng Electronic Technology Co., Ltd. have?

Xiamen Jiashineng Electronic Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Xiamen Jiashineng Electronic Technology Co., Ltd. file in?

Xiamen Jiashineng Electronic Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Xiamen Jiashineng Electronic Technology Co., Ltd.'s most well-known trademarks?

Xiamen Jiashineng Electronic Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as UGIFT. These are among 1 currently registered trademark in the portfolio.

What is Xiamen Jiashineng Electronic Technology Co., Ltd.'s trademark registration success rate?

Xiamen Jiashineng Electronic Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.